drugset / Trial / NCT00824356
Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo
RandomizedCrossoverTriple-blindTreatment
Summary
This is a placebo-controlled, 3-period crossover study to assess the efficacy and safety of two single doses of an intranasal anti-histamine GSK1004723 compared with placebo in an allergen challenge chamber in male subjects with seasonal allergic
Timeline
- Start
- 2008-06
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GSK1004723 | Small molecule | 200 mg | Intranasal |
| Comparator | GSK1004723 | Small molecule | 1000 mg | Intranasal |